WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Earnings & Revenue

ASND past revenue growth

How has ASND's revenue growth performed historically?
Company
322.18%
Industry
89.08%
Market
19.74%
ASND's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ASND's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ASND's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ASND earnings and revenue history

Current Revenue
$357.6M
Current Earnings
-$545.2M
Current Profit Margin
-152.4%

ASND Return on Equity

Current Company
N/A
Current Industry
16.8%
Current Market
28.2%

Be the first to know when ASND announces earnings.

ASND Return on Assets

Current Company
-60.3%
Current Industry
3.2%
ASND is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ASND Return on Capital Employed

Current Company
-10,575.04%
Current Industry
-42.4%
ASND's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ASND vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ASND$353.79M-$381.48M-$539.32M+81.53%N/A
ROIV$124.80M$4.43B$4.35B+16.53%+1.99%
RVMD$4.57M-$477.95M-$484.27M-44.59%N/A
BPMC$282.21M-$246.69M-$288.29M+44.82%N/A
CERE$0.00-$443.48M-$460.47MN/AN/A

ASND earnings dates

Next earnings date
Sep 3, 2024

Ascendis Pharma A Earnings & Revenue FAQ

What were ASND's earnings last quarter?

On Invalid Date, Ascendis Pharma A (NASDAQ: ASND) reported Q1 2024 earnings per share (EPS) of -$2.50, up 16.17% year over year. Total Ascendis Pharma A earnings for the quarter were -$142.43 million. In the same quarter last year, Ascendis Pharma A's earnings per share (EPS) was -$2.15.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

What was ASND's earnings growth in the past year?

As of Q3 2024, Ascendis Pharma A's earnings has grown year over year. Ascendis Pharma A's earnings in the past year totalled -$539.32 million.

What is ASND's earnings date?

Ascendis Pharma A's earnings date is Invalid Date. Add ASND to your watchlist to be reminded of ASND's next earnings announcement.

What was ASND's revenue last quarter?

On Invalid Date, Ascendis Pharma A (NASDAQ: ASND) reported Q1 2024 revenue of $104.23 million up 185.49% year over year. In the same quarter last year, Ascendis Pharma A's revenue was $36.51 million.

What was ASND's revenue growth in the past year?

As of Q3 2024, Ascendis Pharma A's revenue has grown 322.18% year over year. This is 233.1 percentage points higher than the US Biotechnology industry revenue growth rate of 89.08%. Ascendis Pharma A's revenue in the past year totalled $353.79 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.